Impact of Personalized Risk Infographics on Smoking Cessation Counselling in COPD
تأثير الرسوم البيانية المخصصة للمخاطر على استشارات الإقلاع عن التدخين في مرض الانسداد الرئوي المزمن
Journal: BMC pulmonary medicine
University: University of Toronto
Study Type: cohort
Evidence Level: preliminary
Participants: 191
Published:
⚠️ Warning: This is a preliminary study (animal/cell) and has not been proven in humans.
30-Second Summary
A feasibility study investigated the impact of a personalized biomedical risk assessment infographic on smoking cessation counselling for patients with chronic obstructive pulmonary disease. The findings suggest the infographic was associated with increased counselling rates and more frequent changes in respiratory medications, despite a 50% delivery success rate.
1-Minute Summary
Researchers conducted a feasibility study to evaluate a personalized biomedical risk assessment infographic designed to trigger smoking cessation counselling for patients with chronic obstructive pulmonary disease (COPD). The study compared a pre-intervention period of usual care with an intervention period using the infographic at a tertiary care center. Results indicated that smoking cessation counselling occurred in 80.7% of eligible visits during the intervention period, compared to 67.4% during the pre-intervention period. Additionally, changes in respiratory medications were more common during the intervention phase, although the infographic was successfully delivered in only about half of the eligible visits.
3-Minute Summary
This analysis is based exclusively on the provided PubMed abstract titled 'Impact of personalized biomedical risk assessment on smoking cessation counselling in chronic obstructive pulmonary disease,' published in BMC Pulmonary Medicine. It is imperative to state clearly at the outset that this analysis relies entirely on the limited information available in the abstract. Full-text verification is absolutely required to confirm the methodological details, statistical rigor, and complete findings of the study. The study is classified as a preliminary cohort study with a primary topic related to longevity, specifically addressing interventions aimed at modifying behaviors associated with chronic obstructive pulmonary disease (COPD) progression. According to the abstract, smoking cessation is a critical factor that reduces mortality and improves the quality of life for individuals diagnosed with COPD. The authors note that while brief physician counseling is an effective strategy for encouraging smoking cessation, it is frequently underutilized in clinical practice. To address this gap in care, the researchers designed a personalized biomedical risk assessment infographic. This tool was specifically created to depict a patient's predicted future lung function decline, alongside the corresponding clinical consequences, comparing scenarios with and without smoking cessation. The primary objective of this infographic was to trigger and facilitate smoking cessation counseling directly at the point-of-care. The abstract describes the research as a feasibility study designed to evaluate the real-world implementation of this infographic and its subsequent impact on clinical care. The study employed a pre-intervention and post-intervention design over a two-year period at a tertiary care center, identified as St. Michael's Hospital (SMH) at the University of Toronto. Year 1 served as the pre-intervention period representing usual care, followed by Year 2, which served as the intervention period utilizing the infographic. The study recruited pulmonologists and primary care providers who refer patients to the SMH pulmonary function laboratory (PFL). The target patient population consisted of current smokers with COPD who were referred for spirometry by consenting providers. During the intervention period, the infographic was generated through the PFL software and provided to the patients, who were instructed to bring the document to their provider for discussion. The researchers established co-primary behavioral outcomes, which were measured through electronic chart (e-chart) reviews. These outcomes focused on changes in the proportion of clinical visits in which patients either received smoking cessation counseling or were prescribed/recommended smoking cessation pharmacotherapy. The abstract reports that 87 eligible patients were included in the pre-intervention period (median age 66.0 years; 60.0% male), and 104 eligible patients were included in the intervention period (median age 67.5 years; 63.0% male). Regarding the results, the abstract states that smoking cessation counseling was delivered in 67.4% (58 out of 86) of eligible visits during the pre-intervention period, compared to 80.7% (96 out of 119) of eligible visits during the intervention period. This difference was reported with a p-value of 0.045, suggesting a statistically significant increase based on standard thresholds, though the margin is narrow. Conversely, the prescription or recommendation of smoking cessation pharmacotherapy occurred in 11.6% (10 out of 86) of visits during the pre-intervention period and 18.5% (22 out of 119) of visits during the intervention period. The abstract reports a p-value of 0.25 for this outcome, indicating that the observed increase did not reach statistical significance. Additionally, the researchers noted an unexpected finding: changes in respiratory medications were more common during the intervention period (33.6%) compared to the pre-intervention period (22.6%), with a highly significant p-value of less than 0.001. A critical limitation highlighted in the abstract is the intervention fidelity. The researchers report that the successful delivery of the infographic occurred in only 50.4% (60 out of 119) of eligible visits during the intervention period. Despite this low fidelity, the authors conclude that the personalized biomedical risk assessment infographic appears to increase smoking cessation counseling rates and may alter COPD management. They also note that provider feedback was highly favorable. The abstract concludes with a recommendation that the generation of the infographic should be automated to improve delivery rates, and that the intervention should subsequently be evaluated for its direct impact on actual smoking cessation outcomes, which were not the primary focus of this feasibility study. The study was registered at ClinicalTrials.gov (NCT04119934). In summary, this abstract outlines a preliminary feasibility study suggesting that a visual risk assessment tool may influence provider behavior regarding counseling. However, the reliance on a pre-post design without a concurrent control group, combined with a low intervention fidelity rate of approximately 50%, introduces substantial uncertainty. The findings must be interpreted with high caution, and full-text verification is essential to understand the complete context, limitations, and exact nature of the data collected.
Full Analysis
This comprehensive analysis is based exclusively on the provided PubMed abstract titled 'Impact of personalized biomedical risk assessment on smoking cessation counselling in chronic obstructive pulmonary disease,' published in the journal BMC Pulmonary Medicine. The study is classified as a preliminary cohort study concerning longevity and behavioral modification in chronic disease management. It is crucial to emphasize that this analysis is constrained by the limitations of abstract-level information. The abstract provides only a high-level summary of the research rationale, methodology, and selected findings. Therefore, full-text verification is absolutely mandatory to assess the study's methodological rigor, the exact nature of the intervention, the statistical models employed, and the broader context of the results. No clinical, diagnostic, or practical advice should be derived from this analysis, and all findings must be treated as preliminary and uncertain. ### 1. Reported Background and Rationale The abstract establishes its premise on the well-documented clinical understanding that smoking cessation is a primary mechanism for reducing mortality and improving the quality of life in patients with chronic obstructive pulmonary disease (COPD). The authors identify a specific gap in clinical care: while brief physician counseling is known to be an effective intervention for promoting smoking cessation, it is frequently omitted or not provided during patient encounters. To bridge this implementation gap, the research team designed a 'personalized biomedical risk assessment infographic.' According to the abstract, this visual tool was engineered to depict a patient's predicted future lung function decline, juxtaposed with the corresponding clinical consequences that would occur with versus without smoking cessation. The theoretical framework underlying this intervention appears to be rooted in behavioral science, specifically the concept that personalized, visually accessible risk communication can serve as a catalyst or 'trigger' to facilitate counseling at the point-of-care. However, the abstract does not describe the specific visual elements, health literacy considerations, or the algorithms used to calculate the 'predicted future lung function decline.' Full-text verification is necessary to understand how these predictions were formulated and communicated to the patients. ### 2. Methodological Design and Implementation The study is described as a 'feasibility study' utilizing a pre-intervention and post-intervention design. The timeline spanned two years at a tertiary care center, specifically St. Michael's Hospital (SMH) affiliated with the University of Toronto. Year 1 functioned as the pre-intervention period, representing the baseline of 'usual care.' Year 2 served as the intervention period, during which the infographic was introduced into the clinical workflow. The recruitment strategy targeted pulmonologists and primary care providers who routinely refer patients to the SMH pulmonary function laboratory (PFL). The patient cohort consisted of current smokers diagnosed with COPD who were referred for spirometry by these consenting providers. The delivery mechanism for the intervention involved generating the infographic through the PFL software. Patients were provided with this document and instructed to bring it to their subsequent provider visit for discussion. From a research literacy perspective, this design introduces several critical vulnerabilities. A pre-post design without a concurrent, randomized control group is highly susceptible to temporal confounding. Changes in clinical practice, institutional policies, or broader public health campaigns regarding smoking cessation that occurred between Year 1 and Year 2 could independently influence the outcomes, making it difficult to attribute any observed changes solely to the infographic. Furthermore, the delivery mechanism relied heavily on patient compliance (bringing the physical or digital document to the provider), which introduces a significant variable in the intervention's implementation. ### 3. Participant Demographics and Study Size The abstract reports that the study included 87 eligible patients in the pre-intervention period and 104 eligible patients in the intervention period. The demographic data provided is minimal. For the pre-intervention group, the median age was 66.0 years, and the cohort was 60.0% male. For the intervention group, the median age was slightly higher at 67.5 years, with a similar sex distribution of 63.0% male. While the abstract provides these basic medians and percentages, it does not report whether statistical tests were performed to ensure these two sequential cohorts were comparable at baseline. Differences in disease severity, socioeconomic status, baseline motivation to quit smoking, or comorbidities between the Year 1 and Year 2 cohorts could act as confounding variables. Full-text verification is required to review the complete baseline characteristics table and assess the comparability of the two groups. ### 4. Primary Outcomes and Statistical Findings The researchers established co-primary behavioral outcomes, which were evaluated through electronic chart (e-chart) reviews. These outcomes were designed to measure changes in provider behavior rather than patient health outcomes. Specifically, they measured the proportion of visits in which patients (1) received smoking cessation counseling, and (2) were prescribed or recommended smoking cessation pharmacotherapy. For the first co-primary outcome, the abstract reports that smoking cessation counseling was delivered in 67.4% (58 out of 86) of eligible visits during the pre-intervention period. In the intervention period, this rate increased to 80.7% (96 out of 119) of eligible visits. The reported p-value for this comparison is 0.045. In standard statistical hypothesis testing, a p-value of less than 0.05 is generally considered statistically significant. However, a p-value of 0.045 is marginally significant. Given the observational pre-post design and the potential for confounding, this finding should be interpreted with caution. It suggests an association between the intervention period and increased counseling, but does not definitively prove causation. For the second co-primary outcome, the prescription or recommendation of smoking cessation pharmacotherapy was observed in 11.6% (10 out of 86) of visits during the pre-intervention period, compared to 18.5% (22 out of 119) of visits during the intervention period. The reported p-value for this outcome is 0.25. Because this p-value is greater than 0.05, the observed numerical increase cannot be distinguished from random chance. Therefore, based on the abstract, the intervention did not have a statistically significant impact on the prescribing of pharmacotherapy. Interestingly, the abstract reports a secondary or incidental finding regarding respiratory medications. Changes in respiratory medications were significantly more common in the intervention period (33.6%) compared to the pre-intervention period (22.6%), with a highly significant p-value of less than 0.001. The abstract posits that the infographic 'may alter COPD management' beyond just smoking cessation. However, without the full text, it is impossible to know what types of medication changes occurred (e.g., stepping up inhaler therapy) or whether these changes were clinically appropriate or directly triggered by the lung function data presented in the infographic. ### 5. Intervention Fidelity and Feasibility Limitations A pivotal piece of data reported in the abstract is the intervention fidelity rate. The authors state that the successful delivery of the infographic occurred in only 50.4% (60 out of 119) of eligible visits during the intervention period. This means that nearly half of the patients in the intervention cohort did not actually receive or deliver the intended intervention to their provider. This low fidelity rate is a major limitation and is highly characteristic of feasibility studies, which are specifically designed to uncover such implementation challenges before a larger efficacy trial is conducted. The abstract notes that the observed changes in counseling and medication management occurred 'despite' this low delivery rate. However, from an analytical standpoint, this raises questions about how the data was analyzed. Did the researchers use an 'intention-to-treat' approach (analyzing all 119 visits regardless of whether the infographic was delivered) or a 'per-protocol' approach (analyzing only the 60 visits where delivery was successful)? The abstract does not specify, making full-text verification absolutely critical to understanding the true impact of the intervention. The authors acknowledge this limitation by concluding that the generation of the infographic should be automated to improve delivery. The reliance on patients to act as couriers for their own biomedical risk data clearly represented a bottleneck in the intervention's feasibility. ### 6. Reported Limitations and Uncertainties Based strictly on the provided text, several uncertainties and limitations must be preserved in this analysis: 1. **Study Design**: The pre-intervention/post-intervention design is inherently weaker than a randomized controlled trial (RCT) because it cannot control for changes over time (temporal confounding). 2. **Implementation Failure**: The 50.4% delivery rate indicates that the intervention, as designed, was not highly feasible in a real-world workflow without automation. 3. **Outcome Measurement**: The outcomes were measured via 'e-chart review.' This relies entirely on the accuracy and completeness of physician documentation. An increase in documented counseling could reflect an actual increase in counseling, or it could simply reflect better documentation practices over time. 4. **Lack of Patient Outcomes**: The study measured provider behavior (counseling and prescribing). It did not measure whether the patients actually quit smoking, which is the ultimate clinical goal. 5. **Single-Center Setting**: The study was conducted at a single tertiary care center (St. Michael's Hospital), which limits the generalizability of the findings to other healthcare settings, such as community clinics or rural practices. ### 7. Full-Text Verification Requirements To move beyond the preliminary evidence presented in the abstract, an exhaustive review of the full-text manuscript is required to ascertain: * **Infographic Design**: The exact visual layout, data sources, and algorithms used to create the personalized risk assessment. * **Statistical Methodology**: The specific statistical tests used to compare the cohorts, and whether any multivariable regression models were employed to adjust for potential confounders (e.g., age, sex, baseline lung function). * **Analysis Protocol**: Clarification on whether the primary outcomes were analyzed using intention-to-treat or per-protocol principles, given the 50% intervention failure rate. * **Definition of Counseling**: The exact criteria used during the e-chart review to define what constituted 'smoking cessation counseling.' * **Medication Changes**: Detailed data on the types of respiratory medication changes that occurred and the clinical rationale behind them. * **Reasons for Delivery Failure**: Qualitative or quantitative data explaining why the infographic failed to reach the provider in nearly half of the cases. * **Funding and Conflicts of Interest**: Any financial support or potential conflicts of interest that could influence the study's design or interpretation. ### 8. Conclusion The abstract presents preliminary data from a feasibility study suggesting that a personalized biomedical risk assessment infographic might increase the frequency of documented smoking cessation counseling by providers in a COPD population. However, the findings are heavily caveated by a low intervention fidelity rate, a pre-post observational design, and a lack of data on actual smoking cessation outcomes. The authors rightly conclude that the delivery mechanism requires automation and that further evaluation is necessary. This analysis reiterates that these findings are strictly preliminary, heavily reliant on the limited context of an abstract, and require comprehensive full-text verification before any definitive conclusions regarding the intervention's utility can be drawn.Health Implications
This abstract describes a preliminary feasibility study exploring whether a personalized visual infographic showing predicted lung function decline might increase the frequency of doctors providing smoking cessation counseling to patients with COPD. The study suggests that during the period the infographic was available, documented counseling rates by providers increased marginally compared to a previous period. It also noted an increase in changes to respiratory medications. However, it is crucial to understand what this abstract does not establish. It does not prove that the infographic directly caused the increase in counseling, as the study design (comparing two different time periods without a concurrent control group) cannot rule out other factors. Furthermore, the intervention failed to reach the provider in nearly half of the eligible visits, highlighting significant implementation challenges. Most importantly, the study only measured provider behavior (counseling and prescribing); it did not measure whether the intervention actually helped patients quit smoking or improved their long-term health outcomes. The findings are strictly preliminary, highlight the need for automated delivery systems, and require full-text verification to properly assess the statistical and methodological details.
Key Findings
- Smoking cessation counselling was delivered in 80.7% of eligible visits during the intervention period versus 67.4% in the pre-intervention period.
- Changes in respiratory medications were observed more frequently during the intervention period (33.6%) compared to the pre-intervention period (22.6%).
- The personalized infographic was successfully delivered in 50.4% of the eligible visits during the intervention phase.